DOXIMITY INC-CLASS A (DOCS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:DOCS - US26622P1075 - Common Stock
38.96 USD
-1.44 (-3.56%)
39 USD
+0.04 (+0.1%)
DOCS gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 34 industry peers in the Health Care Technology industry. DOCS has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. DOCS is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make DOCS suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
- DOCS had positive earnings in the past year.
- DOCS had a positive operating cash flow in the past year.
- Each year in the past 5 years DOCS has been profitable.
- DOCS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 20.13%, DOCS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- DOCS's Return On Equity of 23.10% is amongst the best of the industry. DOCS outperforms 100.00% of its industry peers.
- DOCS has a better Return On Invested Capital (18.16%) than 100.00% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for DOCS is significantly above the industry average of 6.63%.
- The last Return On Invested Capital (18.16%) for DOCS is above the 3 year average (14.17%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.13% | ||
| ROE | 23.1% | ||
| ROIC | 18.16% |
ROA(3y)13.75%
ROA(5y)12.65%
ROE(3y)16.22%
ROE(5y)15.68%
ROIC(3y)14.17%
ROIC(5y)16.48%
1.3 Margins
- Looking at the Profit Margin, with a value of 40.72%, DOCS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- In the last couple of years the Profit Margin of DOCS has grown nicely.
- Looking at the Operating Margin, with a value of 39.72%, DOCS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- In the last couple of years the Operating Margin of DOCS has grown nicely.
- Looking at the Gross Margin, with a value of 90.20%, DOCS belongs to the top of the industry, outperforming 97.06% of the companies in the same industry.
- DOCS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 39.72% | ||
| PM (TTM) | 40.72% | ||
| GM | 90.2% |
OM growth 3Y6.88%
OM growth 5Y16.16%
PM growth 3Y0.28%
PM growth 5Y33.35%
GM growth 3Y0.66%
GM growth 5Y0.68%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), DOCS is creating value.
- The number of shares outstanding for DOCS has been increased compared to 1 year ago.
- The number of shares outstanding for DOCS has been increased compared to 5 years ago.
- DOCS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 30.47 indicates that DOCS is not in any danger for bankruptcy at the moment.
- DOCS has a Altman-Z score of 30.47. This is amongst the best in the industry. DOCS outperforms 100.00% of its industry peers.
- There is no outstanding debt for DOCS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 30.47 |
ROIC/WACC1.93
WACC9.42%
2.3 Liquidity
- A Current Ratio of 7.79 indicates that DOCS has no problem at all paying its short term obligations.
- DOCS has a Current ratio of 7.79. This is amongst the best in the industry. DOCS outperforms 94.12% of its industry peers.
- A Quick Ratio of 7.79 indicates that DOCS has no problem at all paying its short term obligations.
- The Quick ratio of DOCS (7.79) is better than 94.12% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.79 | ||
| Quick Ratio | 7.79 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 46.43% over the past year.
- Measured over the past years, DOCS shows a very strong growth in Earnings Per Share. The EPS has been growing by 79.21% on average per year.
- DOCS shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.21%.
- The Revenue has been growing by 37.42% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)46.43%
EPS 3Y20.79%
EPS 5Y79.21%
EPS Q2Q%50%
Revenue 1Y (TTM)20.21%
Revenue growth 3Y18.42%
Revenue growth 5Y37.42%
Sales Q2Q%23.16%
3.2 Future
- Based on estimates for the next years, DOCS will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.75% on average per year.
- The Revenue is expected to grow by 11.49% on average over the next years. This is quite good.
EPS Next Y14.19%
EPS Next 2Y11.57%
EPS Next 3Y11.76%
EPS Next 5Y14.75%
Revenue Next Year14.06%
Revenue Next 2Y12.59%
Revenue Next 3Y12.01%
Revenue Next 5Y11.49%
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 23.76, which indicates a rather expensive current valuation of DOCS.
- Based on the Price/Earnings ratio, DOCS is valued a bit cheaper than the industry average as 79.41% of the companies are valued more expensively.
- DOCS is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.87, which is the current average of the S&P500 Index.
- With a Price/Forward Earnings ratio of 22.20, DOCS is valued on the expensive side.
- DOCS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. DOCS is cheaper than 76.47% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of DOCS to the average of the S&P500 Index (25.96), we can say DOCS is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.76 | ||
| Fwd PE | 22.2 |
4.2 Price Multiples
- DOCS's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. DOCS is cheaper than 64.71% of the companies in the same industry.
- 70.59% of the companies in the same industry are more expensive than DOCS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.5 | ||
| EV/EBITDA | 23.28 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The excellent profitability rating of DOCS may justify a higher PE ratio.
PEG (NY)1.67
PEG (5Y)0.3
EPS Next 2Y11.57%
EPS Next 3Y11.76%
5. Dividend
5.1 Amount
- No dividends for DOCS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
DOXIMITY INC-CLASS A / DOCS FAQ
What is the fundamental rating for DOCS stock?
ChartMill assigns a fundamental rating of 7 / 10 to DOCS.
What is the valuation status for DOCS stock?
ChartMill assigns a valuation rating of 4 / 10 to DOXIMITY INC-CLASS A (DOCS). This can be considered as Fairly Valued.
How profitable is DOXIMITY INC-CLASS A (DOCS) stock?
DOXIMITY INC-CLASS A (DOCS) has a profitability rating of 9 / 10.
What are the PE and PB ratios of DOXIMITY INC-CLASS A (DOCS) stock?
The Price/Earnings (PE) ratio for DOXIMITY INC-CLASS A (DOCS) is 23.76 and the Price/Book (PB) ratio is 6.7.
What is the earnings growth outlook for DOXIMITY INC-CLASS A?
The Earnings per Share (EPS) of DOXIMITY INC-CLASS A (DOCS) is expected to grow by 14.19% in the next year.